Henry Masur, M.D.
Critical Care Medicine Department, Clinical Center, NIH, DHHS
Bethesda, Maryland

Presentation Title
HIV Pathogenesis, Current Epidemiology, and Future Course

Dr. Masur is Chief of the Critical Care Medicine Department at the NIH Warren Magnuson Clinical Center. 

A graduate of Dartmouth College, Dr. Masur earned his MD at Cornell University Medical College.  He completed his residency at The New York Hospital and Johns Hopkins Hospital, as a well as a fellowship in infectious diseases at Cornell.

Dr. Masur’s primary research interests are in opportunistic infections in HIV and approaches to therapy for pneumocystosis and toxoplasmosis.
Over the past two decades his department has been
involved in extensive studies of the pathophysiology of Pneumocystis jiroveci pneumonia, leading to the development of new diagnostic tests (including the widely used immunofluorescent test) and PCR assays. The department has also extensively investigated the metabolism of pneumocystis and developed new therapeutic agents.  Dr. Masur has also published on cytomegalovirus (CMV) and Mycobacterium avium complex (MAC) and is co-editor of the National Institutes of Health-Infectious Society of America Guidelines on Prevention of Opportunistic Infections in Persons with HIV and the companion guidelines on therapy of HIV-related opportunistic infections.
     
Dr. Masur also provides leadership to studies assessing the causes of and therapy for metabolic complications associated with HIV, especially increased cardiovascular risk. In a collaborative effort, pulmonary medicine, cardiology, and endocrinology are assessing endothelial cell function as it affects cardiovascular status.

The Critical Care Medicine Department also has a growing program in Emerging Diseases. Multicenter trials are currently underway internationally and nationally in severe acute respiratory syndrome (SARS), avian influenza, HIV, and West Nile virus.